ED vs LAB
Consolidated Edison Inc (ED) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
ED currently screens at market cap $36.02B and trailing P/E 18.3. LAB currently screens at market cap $317.1M.
Not investment advice. Open the ED and LAB stock pages for the full models.
Not investment advice.